Gabapentin Capsule
Product Images NDC 72162-1533

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 72162-1533). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

A line graph showing mean pain scores over an 8-week period comparing Gabapentin 3600 mg/day to placebo. The x-axis represents weeks with a 4-week dose titration period followed by a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10, with Gabapentin showing a greater decrease in pain scores compared to placebo over time.*

FDA Label Image

Figure 2 (Image 02)

A line graph showing mean pain scores over 7 weeks for placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The x-axis represents weeks, starting at baseline, and the y-axis shows mean pain scores from 0 to 10. The graph includes a 3-week dose titration period followed by a 4-week fixed dose period.*

FDA Label Image

Figure 3 (Image 03)

A bar chart titled 'Figure 3. Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and gabapentin (GBP) doses across two studies. It shows the percentage of responders, with Study 1 comparing PBO and GBP 3600 mg, and Study 2 comparing PBO, GBP 1800 mg, and GBP 2400 mg. Significance levels are marked with p-values.*

FDA Label Image

Cockcroft And Gault Equation (Image 04)

A mathematical formula illustrating the calculation of creatinine clearance (ClCr). The formula uses patient's age, weight, serum creatinine level, and a correction factor for female patients. This diagram is an instructional figure showing the ClCr calculation method.*

FDA Label Image

Gabapentin Structural Formula (Image 05)

Chemical structure of gabapentin showing its molecular arrangement with a cyclohexane ring and side chains including an amino group and a carboxyl group.*

FDA Label Image

Image-09 (Image 09)

A scatter plot chart comparing percentage differences by daily dose (mg) across three studies labeled a, b, and c. The x-axis shows daily doses of 600, 900, 1200, and 1800 mg, while the y-axis shows difference percentages from 2% to 22%. Data points are marked with different symbols representing Study a (black squares), Study b (gray squares), and Study c (white squares).*

FDA Label Image

Label (Lbl721621533)

Gabapentin Capsule, USP 300 mg oral dosage form label showing packaging for 100 capsules. Labeled by Bryant Ranch Prepack and manufactured by ScieGen Pharmaceuticals, Inc. Includes storage instructions and a barcode with NDC 72162-1533-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.